Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves

• US 7,369,894 B2
• Filed: 04/30/2004
• Issued: 05/06/2008
• Est. Priority Date: 09/06/2002
• Status: Expired due to Term

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Gerber, Martin T.
• Primary Examiner(s): Layno; Carl
• Assistant Examiner(s): Patel; Natasha
• Application Number:
  US10/836,924
• Publication Number:
  US 20050033372A1
• Time in Patent Office: 1,467 Days
• Field of Search: 607 39- 41, 607/133, 607/138, 607/46
• US Class Current: 607/39
• CPC Class Codes: A61N 1/0507 Electrodes for the digestive system
• CPC Class Codes: A61N 1/0521 Genital electrodes
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/36107 Sexual dysfunction stimulating genital organs A61N1/36007

Abstract

Described are implantable devices and methods for treating various disorders of the pelvic floor by means of electrical stimulation of tissue volumes at two or more locations adjacent sacral nerves or portions thereof, and/or pudendal nerves of portions thereof. Two or more electrical stimulation regimes are applied on a continuous, alternating, intermittent or other basis to the respective tissue volumes in an amount and manner effective to treat a number of disorders, including, but not limited to, urinary and/or fecal voiding dysfurictions such as constipation, incontinence disorders such as urge frequency and urinary retention disorders, sexual dysfunctions such as orgasmic and erectile dysfunction, pelvic pain, prostatitis, prostatalgia and prostatodynia.

Claims

1. A method of treating orgasmic dysfunction the method comprising:

identifying a patient with orgasmic dysfunction;

implanting a distal end of a first implantable medical electrical lead in a first tissue volume of the patient adjacent around or in a left sacral nerve or branches or portions thereof;

implanting a distal end of a second implantable medical electrical lead in a second tissue volume of the patient adjacent, around or in a right sacral nerve or branches or portions thereof;

operably connecting a proximal end of the first lead to an hermetically sealed implantable electrical pulse generator configured to provide at least first and second electrical stimulation pulse regimes via at least the first and second leads;

operably connecting a proximal end of the second lead to the implantable pulse generator;

implanting the implantable pulse generator within the patient; and

delivering, from the implantable pulse generator, first electrical stimulation pulses to the left sacral nerve or branches or portions thereof through the first lead and at least the first electrode, the first pulses being provided in accordance with the first electrical stimulation pulse regime;

delivering, from the implantable pulse generator, second electrical stimulation pulses to the right sacral nerve or branches or portions thereof through the second lead and at least the second electrode, the second pulses being provided in accordance with the second electrical stimulation pulse regime;

wherein the combination of the first and the second electrical pulse regimes is delivered through the first and second leads in a configuration effective to provide at least partial relief from orgasmic dysfunction.

2. The method of claim 1, wherein at least one of the first lead and the second lead is selected from the group consisting of a beam steering lead comprising multiple electrodes and a lead comprising multiple electrodes disposed in an areal pattern on a planar or curved surface.

3. The method of claim 1, wherein at least one of the first lead and the second lead is selected from the group consisting of a cuff lead, a paddle lead, a tined lead, a lead having an active fixation device or member disposed thereon, attached thereto or forming a portion thereof.

4. The method of claim 1, wherein at least one of the first lead and the second lead comprises a fixation mechanism selected from the group consisting of a suture sleeve, a barb, a helical screw, a hook and a tissue in-growth mechanism.

5. The method of claim 1, further comprising delivering electrical pulses through a third tissue volume disposed near or between the electrodes located on the first and second leads.

6. The method of claim 1, wherein at least one of the first lead and the second lead is selected from the group consisting of a lead comprising a lead body less than about 5 mm in diameter, a lead comprising a lead body less than about 1.5 mm in diameter, a lead having a lead body comprising polyurethane or silicone, a lead comprising electrical conductors disposed within the body thereof and extending between the proximal and distal ends of the lead wherein the conductors are formed of coiled, braided or stranded wires, and a lead comprising at least one ring electrode, at least one coiled electrode, at least one button electrode, at least one electrode formed from a portion of wire, a cuff, a barb or a hook, a spherically-shaped electrode, and a helically-shaped electrode.

7. The method of claim 1, wherein an inter-electrode distance of at least one of the first lead and the second lead is selected from the group consisting of about 1 mm, about 2 mm, about 3 mm, about 4 mm, about 5 mm, about 6 mm, about 7 mm, about 8 mm, about 9 mm, about 10 mm, about 12 mm, about 14 mm, about 16 mm, about 18 mm, about 20 mm, about 25 mm, and about 30 mm.

8. The method of claim 1, wherein the at least one electrode of at least one of the first lead and the second lead has an electrode surface area ranging between about 1.0 sq. mm and about 100 sq. mm, between about 2.0 sq. mm and about 50 sq. mm, or between about 4.0 sq. mm and about 25 sq. mm.

9. The method of claim 1. wherein the distance between the proximal and distal ends of at least one of the first lead and the second lead is selected from the group consisting of about 6 inches, about 8 inches, about 10 inches, about 12 inches, about 14 inches, about 16 inches about 18 inches, about 20 inches and more tan about 20 inches.

10. The method of claim 1, wherein the implantable pulse generator and at least one of the first lead and the second lead are capable of generating and delivering electrical pulses having frequencies ranging between about 50 Hz and about 100 Hz, between about 10 Hz and about 250 Hz, or between about 0.5 Hz and about 500 Hz.

11. The method of claim 1, wherein the iniplantable pulse generator and at least one of the first lead and the second lead are capable of generating and delivcring electrical pulses having amplitudes ranging between about 1 Volt and about 10 Volts, between about 0.5 Volts and about 20 Volts, or between about 0.1 Volts and about 50 Volts.

12. The method of claim 1, wherein the implantable pulse generator and at least one of the first lead and the second lead are capable of generating and delivering electrical pulses having pulse widths ranging between about 180 microseconds and about 450 microseconds, between about 100 microseconds and about 1000 microseconds, or between about 10 microseconds and about 5000 microseconds.

13. The method of claim 1, wherein the implantable pulse generator and at least one of the first lead and the second lead are capable of generating and delivering electrical pulses having varying spatial or temporal phases.

14. The method of claim 1, wherein at least one of activation, modification and termination of at least one of the first pulse regime and the second pulse regime is carried out by the patient or a besith care giver.

15. The method of claim 14, wherein the at least one of activation, modification and termination of at least one of the first pulse regime and the second pulse regime is carried out in response to patient symptoms appearing or disappearing, or the patient feeling or not feeling symptoms.

16. The method of claim 14, wherein patient or health care giver activation, modification and/or termination of the first or second pulse regime is accomplished through infra-red, telemetric, radio, magnetic, or ultrasonic means.

17. The method of claim 1, wherein the first pulse regime is delivered while delivery of the second pulse regime is initiated later in response to a sensed physical parameter or symptom.

18. The method of claim 1, wherein die first and second pulse regimes are initially delivered, and delivery of at least one of the first and second pulse regimes is subsequently terminated or modified.

19. The method of claim 1, wherein at least one of the first pulse regime and the second pulse regime is one of activated, modified and terminated in response to a physical parameter or symptom being sensed.

20. The method of claim 19, wherein the physical parameter is sensed using a sensor selected from the group consisting of nerve electrical signal sensor and an electromyographic sensor.

21. The method of claim 1, further comprising delivering a drug to the patient.

22. The method of claim 21, further comprising providing, implanting and activating an implantable drug pump for providing the drug to the patient.

23. A method of treating erectile dysunction, the method comprising:

identifying a patient with erectile dysfunction;

implanting a distal end of a first implantable medical electrical lead in a first tissue volume of the patient adjacent, around or in a pudendal nerve or branches or portions thereof;

implanting a distal end of a second implantable medical electrical lead in a second tissue volume of the patient adjacent, around or in one of the pudendal nerve, another pudendal nerve, a sacral nerve, or branches or portions thereof;

operably connecting a proximal end of the first lead to an hermetically sealed implantable electrical pulse generator configured to provide at least first and second electrical stimulation pulse regimes via at least the first and second leads;

operably connecting a proximal end of the second lead to the implantable pulse generator;

implanting the implantable pulse generator within the patient; and

delivering, from the implantable pulse generator, first electrical stimulation pulses to the pudendal nerve or branches or portions thereof through the first lead and at least the first electrode, the first pulses being provided in accordance with the first electrical stimulation pulse regime;

delivering, from the implantable pulse generators second electrical stimulation pulses to the one of the pudendal nerve, another pudendal nerve, sacral nerve, or branches or portions thereof through the second lead and at least the second electrode, the second pulses being provided in accordance with the second electrical stimulation pulse regime;

wherein the combination of the first and the second electrical pulse regimes is delivered through the first and second leads in a configuration effective to provide at least partial relief from erecrile dysfunction.

24. The method of claim 23, wherein the second tissue volume is adjacent, around or in one of the sacral nerves or branches or portions thereof.

25. The method of claim 23, wherein the first and second tissue volumes ate located in respective ones of right and left sides of the patient.

26. A method of treating at least one diagnosed pelvic floor disorder in a patient, the at least one disorder being selected from the group consisting of urinary voiding dysfunction, fecal voiding dysfunction, constipation, stress incontinence, urge incontinence, urinary retention disorder, sexual dysfunction, orgasmic dysfunction, erectile dysfunction, pelvic pain, prostatitis, prostatalgia and prostatodynia, the method comprising:

implanting a distal end of a first implantable medical electrical lead in a first tissue volume of the patient adjacent, around or in a sacral nerve or branches or portions thereof on a first side of a patient;

implanting a distal end of a second implantable medical electrical lead in a second tissue volume of the patient adjacent, around or in a pudendal nerve or branches or portions thereof on a second side of a patient;

operably connecting a proximal end of the first lead to an hermetically sealed implantable electrical pulse generator configured to provide at least first and second electrical stimulation pulse regimes via at least the first and second leads;

operably connecting a proximal end of the second lead to the implantable pulse generator;

implanting the implantable pulse generator within the patient; and

delivering, from the implantable pulse generator, first electrical stimulation pulses to the sacral nerve or branches or portions thereof on a first side of a patient through the first lead and at least the first electrode, the first pulses being provided in accordance with the first electrical stimulation pulse regime;

delivering, from the implantable pulse generator, second electrical stimulation pulses to the pudendal nerve or branches or portions thereof on a second side of a patient through the second lead and at least the second electrode, the second pulses being provided in accordance wit the second electrical stimulation pulse regime;

wherein the combination of the first and the second electrical pulse regimes is delivered through the first and second leads in a configuration effective to provide at least partial relief from at least one of urinary voiding dysfunction, fecal voiding dysftmnction, constipation, stress incontinence, urge incontinence, urinary retention disorder, sexual dysfunction, orgasmic dysfunction, erectile dysfunction, pelvic pain, prostatitis, prostatalgia or prostatodynia.